低收入和中等收入国家非传染性疾病预防与控制干预的实施研究:一项系统综述
该综述系统检索了1990年至2020年MEDLINE和EMBASE数据库,纳入222项在62个国家开展的实施研究,评估265项世界卫生组织优先非传染性疾病预防与控制干预。研究发现筛查类干预占49%、治疗类占39%、预防类占12%,可行性(38%)是最常研究的实施结局,仅不足5%的研究使用实施研究框架。作者认为该领域存在重大科学空白,未来研究应优先关注规模化实施、更高层级卫生系统及可持续性。
要点
- 共纳入222项研究,覆盖62个国家,其中6%在低收入国家、90%在中等收入国家。
- 筛查类干预占49%、治疗类占39%、预防类占12%,预防类中80%针对行为危险因素。
- 可行性(38%)和采纳(23%)是最常研究的实施结局,可持续性研究很少。
核心结论
- 尽管低收入和中等收入国家非传染性疾病实施研究有所增长,但该领域存在重大科学空白。
- 未来研究应优先关注规模化实施、针对更高层级卫生系统(中观和宏观层面)以及检验非传染性疾病项目的可持续性。
- 未来研究应采用内部效度更强的设计、更多概念驱动并使用混合方法理解机制。
- 在有限资源下最大化研究影响,将实施科学结局加入效果研究和区域合作是有前景的方向。
研究设计与样本
- 系统综述,2021年1月20日检索MEDLINE和EMBASE数据库1990年至2020年的文献。
- 纳入标准为聚焦世界卫生组织优先非传染性疾病预防与控制干预、在低收入和中等收入国家卫生系统内提供、报告实施结局的实证同行评议研究。
- 共筛选9683项潜在研究和7419条唯一记录,最终纳入222项符合条件的研究,评估265项在62个国家实施的优先干预。
- 鉴于纳入研究目标和方法异质性,未进行偏倚风险评估,而是评述研究设计分布并讨论较强与较弱的设计。
- 研究方案已在PROSPERO注册(CRD42021252969),采用描述性统计合成提取数据。
主要发现
- 222项研究评估了265项优先非传染性疾病预防与控制干预,在62个国家实施(6%在低收入国家,90%在中等收入国家)。
- 发表研究数量随时间增加,近40%的研究关于宫颈癌。
- 干预类型中筛查占49%、治疗占39%、预防占12%,预防类中80%聚焦非传染性疾病行为危险因素的预防。
- 可行性(38%)是最常研究的实施结局,其次为采纳(23%),很少研究涉及可持续性。
- 大多数研究使用定量方法(86%),最弱设计(前实验)占25%,最强设计(实验)占24%;约72%报告资助且国际资助为主;88%为概念验证或试点,79%针对卫生系统微观层面,不足5%使用实施研究框架。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出鉴于纳入研究目标和方法异质性,未进行偏倚风险评估。
- 原文指出实施策略未被充分说明。
- 原文指出不足5%的研究报告使用实施研究框架。
- 原文指出很少研究涉及可持续性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While the evidence for the clinical effectiveness of most noncommunicable disease (NCD) prevention and treatment interventions is well established, care delivery models and means of scaling these up in a variety of resource-constrained health systems are not. The objective of this review was to synthesize evidence on the current state of implementation research on priority NCD prevention and control interventions provided by health systems in low- and middle-income countries (LMICs). METHODS AND FINDINGS: On January 20, 2021, we searched MEDLINE and EMBASE databases from 1990 through 2020 to identify implementation research studies that focused on the World Health Organization (WHO) priority NCD prevention and control interventions targeting cardiovascular disease, cancer, diabetes, and chronic respiratory disease and provided within health systems in LMICs. Any empirical and peer-reviewed studies that focused on these interventions and reported implementation outcomes were eligible for inclusion. Given the focus on this review and the heterogeneity in aims and methodologies of included studies, risk of bias assessment to understand how effect size may have been compromised by bias is not applicable. We instead commented on the distribution of research designs and discussed about stronger/weaker designs. We synthesized extracted data using descriptive statistics and following the review protocol registered in PROSPERO (CRD42021252969). Of 9,683 potential studies and 7,419 unique records screened for inclusion, 222 eligible studies evaluated 265 priority NCD prevention and control interventions implemented in 62 countries (6% in low-income countries and 90% in middle-income countries). The number of studies published has been increasing over time. Nearly 40% of all the studies were on cervical cancer. With regards to intervention type, screening accounted for 49%, treatment for 39%, while prevention for 12% (with 80% of the latter focusing on prevention of the NCD behavior risk factors). Feasibility (38%) was the most studied implementation outcome followed by adoption (23%); few studies addressed sustainability. The implementation strategies were not specified well enough. Most studies used quantitative methods (86%). The weakest study design, preexperimental, and the strongest study design, experimental, were respectively employed in 25% and 24% of included studies. Approximately 72% of studies reported funding, with international funding being the predominant source. The majority of studies were proof of concept or pilot (88%) and targeted the micro level of health system (79%). Less than 5% of studies report using implementation research framework. CONCLUSIONS: Despite growth in implementation research on NCDs in LMICs, we found major gaps in the science. Future studies should prioritize implementation at scale, target higher levels health systems (meso and macro levels), and test sustainability of NCD programs. They should employ designs with stronger internal validity, be more conceptually driven, and use mixed methods to understand mechanisms. To maximize impact of the research under limited resources, adding implementation science outcomes to effectiveness research and regional collaborations are promising.
引用
- Hategeka C, Adu P, Desloge A, et al. Implementation research on noncommunicable disease prevention and control interventions in low- and middle-income countries: A systematic review. PLoS Med. 2022. PMID: 35877677. doi:10.1371/journal.pmed.1004055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。